LuisCarrilloMD

PubMed

• 23 citations
  Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
  Carolina Schinke, Alexandra M Poos, Michael Bauer, Lukas John, Sarah Johnson, Shayu Deshpande, Luis Carrillo, Daisy Alapat, Leo Rasche, Sharmilan Thanendrarajan, Mauri...> ;Blood Advances. 2022 Nov 22
• Fluorescent-Activated Cell Sorting (Flow Cytometry).
  Luis Carrillo> ;Methods in Molecular Biology. 2022 Jan 1
• Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
  David Baker, Milan Bimali, Luis Carrillo, Archana Sachedina, Daisy Alapat, Md Shadiqul Hoque, Mathew Kottarathara, Richa Parikh, Amani Erra, Angel A Mitma, Pankaj Math...> ;Haematologica. 2021 Dec 1
• 2 citations
  Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
  Parikh, R., Baker, D., Bimali, M., Carrillo, L., Sachedina, A., Alapat, D., Hoque, M., Kottarathara, M., Parikh, R., Erra, A., Mitma, A., Mathur, P., Ogunsesan, Y., Ya...> ;Haematologica. 2021 Aug 12
• 4 citations
  Secretory carcinoma of the parotid with adenoid cystic carcinoma cytological pattern: A cytological-pathological correlation with literature review.
  Oleksandr Kravtsov, Bryan Hunt, Jess F. Peterson, Luis Carrillo, Peter Bonneau, Tamara Giorgadze> ;Annals of Diagnostic Pathology. 2018 Apr 1
• 47 citations
  Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
  Jose A. Plaza, Alexander C. Mackinnon, Luis Carrillo, Victor G. Prieto, Martin Sangueza, Saul Suster> ;The American Journal of Dermatopathology. 2015 Nov 1
• Join now to see all